Media Summary: Dr. Allan, a Lawson scientist in the London Regional Cancer Program, is a national leader in the study of "In 2012, 13.7 million people had a history of This brief video provides an overview of the benefits of the
Cellsearch Circulating Tumor Cell Test - Detailed Analysis & Overview
Dr. Allan, a Lawson scientist in the London Regional Cancer Program, is a national leader in the study of "In 2012, 13.7 million people had a history of This brief video provides an overview of the benefits of the Robert McCormack, PhD, head, Technology Innovation, Janssen Diagnostics, LLC, explains the Howard Scher, MD, from Memorial Sloan-Kettering Cancer Center on the future of the If I have early or late-stage disease should I get a
Howard Scher, MD, from Memorial Sloan-Kettering Cancer Center on using the Susanne Osanto, MD, PhD, from the Leiden University Medical Center, Leiden, Netherlands, discusses the clinical utility of ... ... the United States and we actually collected blood specimens to be able to evaluate